BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30070011)

  • 1. Low-density lipoprotein receptor-related protein 6 regulates alternative pre-mRNA splicing.
    Yuan T; Wang S; Hu C; Wu Y; Liang D; Li L; Liu Y; Li J; Chen YH
    J Cell Mol Med; 2018 Oct; 22(10):4653-4663. PubMed ID: 30070011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
    Peröbner I; Karow M; Jochum M; Neth P
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRP6 regulates Rab7-mediated autophagy through the Wnt/β-catenin pathway to modulate trophoblast cell migration and invasion.
    Li L; Peng W; Zhou Q; Wan JP; Wang XT; Qi HB
    J Cell Biochem; 2020 Feb; 121(2):1599-1609. PubMed ID: 31544984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway.
    Xu Y; Chen D; Lin XX; Zhao Q; Guo J; Chen LJ; Zhang W; Xiao J; Lian GH; Peng SF; Guo D; Yang H; Obianom O; Shu Y; Chen Y
    Arch Toxicol; 2019 Jun; 93(6):1679-1695. PubMed ID: 30976847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis.
    Go GW
    Nutrients; 2015 Jun; 7(6):4453-64. PubMed ID: 26046396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of LRP6 by Src and Fer inhibits Wnt/β-catenin signalling.
    Chen Q; Su Y; Wesslowski J; Hagemann AI; Ramialison M; Wittbrodt J; Scholpp S; Davidson G
    EMBO Rep; 2014 Dec; 15(12):1254-67. PubMed ID: 25391905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of a regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart.
    Ashiya M; Grabowski PJ
    RNA; 1997 Sep; 3(9):996-1015. PubMed ID: 9292499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.
    Makeyev EV; Zhang J; Carrasco MA; Maniatis T
    Mol Cell; 2007 Aug; 27(3):435-48. PubMed ID: 17679093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRP6 acts as a scaffold protein in cardiac gap junction assembly.
    Li J; Li C; Liang D; Lv F; Yuan T; The E; Ma X; Wu Y; Zhen L; Xie D; Wang S; Liu Y; Huang J; Shi J; Liu Y; Shi D; Xu L; Lin L; Peng L; Cui J; Zhu W; Chen YH
    Nat Commun; 2016 Jun; 7():11775. PubMed ID: 27250245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
    Park DS; Seo JH; Hong M; Choi SC
    Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor heterodimerization as a novel mechanism for the regulation of Wnt/β-catenin signaling.
    Lee K; Shin Y; Cheng R; Park K; Hu Y; McBride J; He X; Takahashi Y; Ma JX
    J Cell Sci; 2014 Nov; 127(Pt 22):4857-69. PubMed ID: 25271056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein receptor-related protein 6 is a novel coreceptor of protease-activated receptor-2 in the dynamics of cancer-associated β-catenin stabilization.
    Nag JK; Kancharla A; Maoz M; Turm H; Agranovich D; Gupta CL; Uziely B; Bar-Shavit R
    Oncotarget; 2017 Jun; 8(24):38650-38667. PubMed ID: 28418856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament and meniscus injury.
    Joiner DM; Less KD; Van Wieren EM; Hess D; Williams BO
    Osteoarthritis Cartilage; 2013 Oct; 21(10):1576-85. PubMed ID: 23756208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waif1/5T4 inhibits Wnt/β-catenin signaling and activates noncanonical Wnt pathways by modifying LRP6 subcellular localization.
    Kagermeier-Schenk B; Wehner D; Ozhan-Kizil G; Yamamoto H; Li J; Kirchner K; Hoffmann C; Stern P; Kikuchi A; Schambony A; Weidinger G
    Dev Cell; 2011 Dec; 21(6):1129-43. PubMed ID: 22100263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Catenin-Independent Roles of Wnt/LRP6 Signaling.
    Acebron SP; Niehrs C
    Trends Cell Biol; 2016 Dec; 26(12):956-967. PubMed ID: 27568239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP6AP2, a regulator of LRP6/β-catenin protein trafficking, promotes Wnt/β-catenin signaling and bone formation in a cell type dependent manner.
    Xiong L; Guo HH; Pan JX; Ren X; Lee D; Chen L; Mei L; Xiong WC
    Bone Res; 2024 May; 12(1):33. PubMed ID: 38811544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulated low-density lipoprotein receptor-related protein 6 induces the maldevelopment of extravillous trophoblast via Wnt/β-catenin signaling pathway.
    Yu X; Zhang Y; Yang P; Gao X; Wang Y
    Mol Cell Probes; 2019 Apr; 44():21-28. PubMed ID: 30684559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing regulation of membrane trafficking genes during myogenesis.
    Hinkle ER; Wiedner HJ; Torres EV; Jackson M; Black AJ; Blue RE; Harris SE; Guzman BB; Gentile GM; Lee EY; Tsai YH; Parker J; Dominguez D; Giudice J
    RNA; 2022 Apr; 28(4):523-540. PubMed ID: 35082143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer's disease.
    Alarcón MA; Medina MA; Hu Q; Avila ME; Bustos BI; Pérez-Palma E; Peralta A; Salazar P; Ugarte GD; Reyes AE; Martin GM; Opazo C; Moon RT; De Ferrari GV
    Neurobiol Aging; 2013 Jun; 34(6):1709.e9-18. PubMed ID: 23218566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.